BHP Billiton Ltd. (NYSE: BHP | charts | news | PowerRating) together with its subsidiaries, engages in mining, drilling, and processing mineral resources. It operates through seven segments: Petroleum, Aluminium, Base Metals, Carbon Steel Materials, Diamonds and Specialty Products, Energy Coal, and Stainless Steel Materials. The Petroleum segment engages in the exploration for and production, processing, and marketing of hydrocarbons, including oil, gas, and liquefied natural gas. The Aluminium segment explores and mines bauxite, as well as processes and markets aluminium and alumina. The Base Metals segment engages in the exploration for and mining, processing, and marketing of copper, silver, zinc, lead, uranium, and copper by-products, including gold. The Carbon Steel Materials segment engages in the exploration for and mining, processing, and marketing of coking coal, iron ore, and manganese. The Diamonds and Specialty Products segment includes exploration and mining of diamonds and titanium minerals, and fertilizer operations. The Energy Coal segment engages in the exploration for and mining, processing, and marketing of energy coal. The Stainless Steel Materials segment engages in the exploration for and mining, processing, and marketing of nickel. BHP Billiton operates primarily in Australia, South America, Africa, and Canada. The company was founded in 1885 and is headquartered in Melbourne, Australia. BHP Billiton Ltd. operates as a subsidiary of BHP Billiton Group. With 2.86 billion shares outstanding and 4.43 million shares declared short as of November 2007, there is no longer a failure to deliver in shares of BHP.
EHouse Holdings Ltd. (NYSE: EJ | charts | news | PowerRating) provides real estate agency services, real estate brokerage services, and real estate consulting and information services in the People's Republic of China. It primarily provides real estate agency services to residential property developers. The company also offers real property brokerage services, and intends to provide listing and brokerage services, which include sales and rentals. E-House (China) Holdings focuses its real estate brokerage services in three metropolitan areas within China, including Shanghai, Wuhan, and Hangzhou, as well as in Hong Kong and Macau. Its real estate consulting and information services include land acquisition consulting and property development consulting; and consulting services to investors interested in purchasing businesses with land or other real estate assets, as well as to banks, real estate trade associations, and governmental property and planning agencies. The company was founded in 2000 and is headquartered in Shanghai, the People's Republic of China. With 14.6 million shares outstanding and 288,400 shares declared short as of November 2007, there is no longer a failure to deliver in shares of EJ.
Artes Medical Inc. (NASDAQ: ARTE | charts | news | PowerRating) a medical technology company, focuses on the development, manufacture, and commercialization of injectable aesthetic products for the dermatology and plastic surgery markets in the United States. It offers ArteFill, a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds. Artes Medical markets and sells ArteFill to dermatologists, plastic surgeons, and cosmetic surgeons through its direct sales force. The company, formerly known as Artes Medical USA, Inc., was founded in 1999 and is headquartered in San Diego, California. With 16.48 million shares outstanding and 352,500 shares declared short as of November 2007, there is no longer a failure to deliver in shares of ARTE.
Gentium SpA Gentium SpA (NASDAQ: GENT | charts | news | PowerRating) a biopharmaceutical company, engages in the research, development, and manufacture of drugs to treat and prevent various vascular diseases and conditions related to cancer and cancer treatments. It manufactures defibrotide to treat deep vein thrombosis, and to treat and prevent various vascular diseases with risk of thrombosis. The company also conducts Phase III clinical trials of defibrotide to treat Veno-Occlusive Disease with multiple-organ failure; and phase I/II clinical trials to treat multiple myeloma. In addition, Gentium offers urokinase, which is used to treat various vascular disorders, such as deep vein thrombosis and pulmonary embolisms; and heparin calcium, which is used for the treatment of certain types of lung, blood vessel, and heart disorders, and administration during or after certain types of surgery, such as open heart and bypass surgeries. Further, it manufactures sulglicotide, which is intended to treat peptic ulcers. Additionally, Gentium develops a formulation of the drug mesalazine to treat inflammatory bowel disease. It sells its products primarily in Italy. The company was founded in 1993 as Pharma Research S.r.L. and changed its name to Gentium S.p.A. in 2001. Gentium is based in Villa Guardia, Italy. With 14.28 million shares outstanding and 669,100 shares declared short as of November 2007, there is no longer a failure to deliver in shares of GENT.
Evolving Gold Corp (OTCBB: EVOGF | charts | news | PowerRating) is an emerging exploration and development company focused on building value through the acquisition and exploration of world class prospective gold properties primarily in the southwestern United States, in particular Nevada. With 28.13 million shares outstanding and 300 shares declared short as of November 2007, there is no longer a failure to deliver in shares of EVOGF.
Symbol changed to IVITE (OTCBB: IVIT | charts | news | PowerRating) operates as an Internet media company. It provides email broadcasting to travel enthusiasts seeking discounted travel products. The company offers perishable travel products, including car rentals, airline seats, hotels rooms, cruise cabins, and packaged tours through its Web site, travelhotlink.com. Invicta Group was founded in 2000 and is headquartered in Ft. Lauderdale, Florida. With 530,000 shares outstanding and 100 shares declared short as of November 2007, there is no longer a failure to deliver in shares of IVIT.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 1,700,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
|
|
